Efficacy of insulin targeted gene therapy for type 1 diabetes mellitus: A systematic review and meta-analysis of rodent studies

  • سال انتشار: 1398
  • محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 23، شماره: 4
  • کد COI اختصاصی: JR_IJBMS-23-4_001
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 638
دانلود فایل این مقاله

نویسندگان

Moosa Rahimi Ghiasi

Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Hamed Mohammadi

Food Security Research Center, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran

Michael Symonds

The Early Life Research Unit, Division of Child Health, Obstetrics and Gynaecology, and Nottingham Digestive Disease Centre and Biomedical Research Centre, School of Medicine, University of Nottingham, Nottingham, UK

Seyed Mohammad Bagher Tabei

Department of Genetics & Maternal-Fetal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

چکیده

Objective(s): Diabetes mellitus (DM) is a major worldwide public health challenge, for which gene therapy offers a potential therapeutic approach. To date, no systematic review or meta-analysis has been published in this area, so we examined all relevant published studies on rodents to elucidate the overall effects of gene therapy on bodyweight, intraperitoneal glucose tolerance test (IPGTT), fasting blood glucose, and insulin in animals with type 1 DM. Materials and Methods: The Cochrane Library, PubMed, Embase, ISI Web of Science, SCOPUS, and Google Scholar were systematically searched for potentially relevant studies. Mean±standard deviation (SD) was pooled using a random-effects model.Results: After the primary search, out of 528 studies identified, 16 studies were in concordance with predefined criteria and selected for the final assessment. Of these, 12 studies used viral manipulation, and 4 employed non-viral vectors for gene delivery. The meta-analysis showed gene therapy with a viral vector decreased mean IPGTT (-12.69 mmol/l, P< 0.001), fasting blood glucose (-13.51 mmol/l, P< 0.001), insulin (398.28 pmol/l, P< 0.001), and bodyweight (24.22 g, P< 0.001), whereas non-viral vectors reduced fasting glucose (-29.95 mmol/l, P< 0.001) and elevated insulin (114.92 pmol/l, P< 0.001).Conclusion: Gene therapy has favorable effects on alleviating type 1 DM related factors in diabetic rodents.

کلیدواژه ها

Gene Therapy, Insulin, Meta-analysis, Non-viral vector, Type 1 Diabetes Mellitus, Viral vector

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.